oppn parties WHO Alert For Contaminated Syrups: India's Reputation As The Pharmacy Of The World Is At Stake

News Snippets

  • SP drops two candidates owing allegiance to Azam Khan from Rampur and Moradabad
  • In Assam, a controversy erupted after a picture of UPPL leader Benjamin Basumatary, lying on a stack of Rs 500 notes circulated on social media. UPPL is an ally of the BJP
  • AAP's Jalandhar-West MP Sushil Kumar Rinku joins the BJP. He was the only AAP Lok Sabha MP
  • Supreme Court dismisses Centre's plea to review its 2023 verdict in the PMLA case
  • Close save for passengers as they remain unhurt after the wings of two planes graze at Kolkata airport. Pilots derostered and inquiry ordered by DGCA
  • Bengal BJP leader Dilip Ghosh gets notice from the EC as well as the BJP for making ugly remarks about Mamata Banerjee's parentage
  • Sadanand Vasanth Date, who faught terrorists in the 26/11 attack and was awarded the Preisent's Police medal, has been appointed the head of the NIA
  • Centre will borrow Rs 7.5L cr in the first six months of FY25, nearly 50% of the target for the full year
  • 25 stocks, including SBI, will see same day trade settlements from today in the world's fastest settlement mode in both BSE and NSE
  • Stocks recover smartly on Wednesday: Sensex rises 526 points to 72996 and Nifty 118 points to 22123
  • Tennis: Rohan Bopanna-Matthew Ebden reached the semifinals of the Miami Open
  • IPL: records tumble as SRH beat MI in a high-scoring match. SRH score 277/3 with 18 sixes and Mumbai score 246 with 20 sixes to fall short by 31 runs. Atotal of 38 sixes, highest in an IPL match were hit and both teams combined to score 523 runs, the highest aggregate in an IPL match
  • Amul will launch fresh milk in the US
  • IPL: RCB beat Punjab by 4 wickets as Kohli and Karthik shine with the bat
  • India strongly objected to German foreign office remarks over the arrest of delhi CM Arvind Kejriwal, called it "biased assumptions"
Delhi Lt Governor Vinai Kumar Saxena says government cannot be run from jail, hints at President's Rule in the capital ////// In a dangerous incident, the wings of two planes grazed while taxiing on the runway at Kolkata airport, all passengers were safe but DGCA ordered an inquiry and the pilots were derostered
oppn parties
WHO Alert For Contaminated Syrups: India's Reputation As The Pharmacy Of The World Is At Stake

By A Special Correspondent
First publised on 2022-10-07 02:19:42

Gambia has recalled the four Indian cough syrups manufactured by Sonepat, Haryana-based Maiden Pharmaceuticals from pharmacies after the WHO alert that the syrups were, probably (pending detailed analysis), responsible for the death of 66 children in that country. The syrups were allegedly found to have a combination of several drugs some of which were found to exceed the permissible limits which probably led to the death of the children. WHO has recommended that the drug regulator in the originating country, meaning India, should conduct a thorough probe to find out the truth.

Basically, the WHO alert means that India will have to probe three things - whether the company was licensed to manufacture and export the alleged combinations; to which countries did the company export the products (and whether they were sold in any country other than where exported, through transshipment or otherwise) and whether the company did use certain chemicals beyond permissible limits as alleged.

The Indian authorities have issued a preliminary statement that said that the charged company had been permitted to manufacture the syrups for export only and not for sale in India. It also added that as per available data, the syrups had been exported only to Gambia. But that is not the only brief that the drug regulator in India should be seized with. In its alert, WHO said that the syrups were "substandard (contaminated) paediatric medicines". India needs to conduct a thorough probe. It has been reported that the samples have been sent for testing and the report will be out in two days.

It is not for nothing that India is called the pharmacy of the world. Indian drug manufacturers are renowned and respected for manufacturing good generic medicines that are used all over the world. One bad fish can spoil the reputation and severely dent the goodwill generated through ethical practices followed by drug manufacturers for years. Hence, it is in the interest of India to probe Maiden Pharmaceuticals and inspect its manufacturing facilities to discover the truth. The said company should be handed the maximum punishment prescribed by law to deter others and protect India's hard-earned reputation if it is found guilty.